Pilot Phase Clause Samples

Pilot Phase. (a) During the Pilot Phase, the responsibility of the Parties for costs and expenses will be as set forth in Schedule 3.1(a). Without the approval of the JDC, neither Party will incur any capital expenditures in the performance of the Pilot Phase except as expressly set forth in the Development Plan. (b) […***…]. The JDC will determine whether the technical and commercial key performance indexes (KPIs) for the Pilot Phase, as set forth in the Development Plan (the “Commercialization KPIs”) have been satisfied. The Pilot Phase will continue until the date that the principal tasks in the Development Plan (and any other tasks reasonably determined by Genomatica) have been completed, whether or not the Commercialization KPIs have been satisfied.

Pilot Phase. During the period of performance of the Joint Development Program (the “Pilot Phase”), the objective is to demonstrate the ability to manufacture Bio-BDO via the Bioprocess using cellulosic sugars generated from Biomass feedstocks via the PROESA™ Process Technology in the Pilot Plant Facility. The principal tasks in the Pilot Phase shall consist of those matters set forth in the Development Plan.

Pilot Phase. The Pilot Phase will involve defined group/s of SEIU 521 represented workers/Supervisors and management teams, as determined in the Design Phase, implementing the proposed operational model/s for a set period of time. During the Pilot Phase there will be regular check-ins, which will include iterative fine tuning, gathering data, and recognizing best practices and lessons learned. The Pilot Phase will continue for up to one (1) year.

Pilot Phase. (1) Upon completion of the Analytical Phase Sandoz shall implement the Process in its facilities and Manufacture the Pilot Batches of the API, although not necessarily in compliance with the API Specifications, for the purpose of qualifying the Process. In accordance with the Technology Transfer Plan, the Pilot Phase shall run for a minimum of **) **, with the actual number of total ** to be agreed upon by Unigene and Sandoz based on the results of the Pilot Phase. The parties acknowledge that Sandoz’s ability to conduct the Pilot Phase in accordance with this timetable is dependent on timely delivery by Unigene in accordance with the Technology Transfer Plan of agreed-upon Process Transfer Information. The parties agree to use their commercially reasonable endeavors to ensure that the timeline for the Pilot Phase is met. (2) If during the Pilot Phase the parties identify an unforeseeable technical problem, which prevents Sandoz from Manufacturing the Pilot Phase Batches, then the following procedure shall apply: (a) Sandoz may request further reasonable technical assistance from Unigene and Unigene shall according to Clause 4(8)(a)provide technical assistance as reasonably deemed appropriate by Sandoz. (b) Sandoz shall use its commercially reasonable endeavors to resolve the problem to both parties’ satisfaction and Unigene shall be entitled to have a representative present at the Sandoz site and to fully participate in solving such problem to ensure that this provision is satisfied. (3) If the parties are unable to resolve the problem in the manner described in Clause 3(2)(b) and are not progressing to a mutually agreeable resolution of the problem within a minimum of **) weeks of identification thereof, then Sandoz may terminate this Agreement, in which case the parties’ obligations hereunder shall terminate, other than each party’s obligation of confidentiality and to return the other party’s Confidential Information. (4) Subject to completion of the Pilot Phase, Sandoz will conduct the Demonstration Lot Campaign, and will deliver the Product produced therefrom to Novartis Pharma AG upon completion of such campaign. The parties agree that the Demonstration Lot Campaign means that Sandoz shall Manufacture (a) up to ** Engineering Batches of API and (b) ** cGMP Batches of API that meet the API Specifications, within the timeline stated in Clauses 9(1)(c) and 11(1). If during the Demonstration Lot Campaign the parties identify an unforeseeable technical p...

Pilot Phase. A Pilot Phase is a test period where potential customers can test the GreenChek Unit on their equipment to determine if the Unit works. A Pilot Phase will typically consist of thee activities. They are: 1. The establishment of an emissions and fuel efficiency baseline using the Monitor. 2. The installation of a GreenChek Unit and operation of that Unit for a period of no less than three months. 3. The determination of an emissions and fuel efficiency improvement using the Monitor. For the first three (3) agreed upon Pilots the Distributor will discuss with GreenChek and agree on the number of Units to be tested by a customer or potential customer during a Pilot Phase. The Distributor and GreenChek shall work together in a mutually supportive manner in the best interests of the customer or the potential customer throughout the Pilot Phase. GreenChek reserves the right to limit the amount of Units to be tested during this phase.

Pilot Phase. During the post-pilot phase the outreach events should be focused on retrieving the stakeholders feedback about the platform and providing brief online courses to make a long and lasting impact. Our strategy involves the use of a MOOC platform to deliver the online course content. The activities to be carried out during this phase are: Despite the advantages offered by these programs to people with disabilities, their level of accessibility leaves much to be desired. Although research into accessibility of MOOC is still limited, findings show that many MOOC platforms and programs do not comply with current accessibility standards. Since SoCaTel aims to help elderly people who usually have some kind of medical situation or disability, we aim to deliver learning courses that comply with the Universal Accessibility / Design for all requirements. In addition to course content, other issues need to be taken into account: ● Choose a MOOC platform that complies with WCAG 2.0 recommendations ● Make the registration process accessible ● Pages containing general information about the courses must be accessible ● Allow students to complete accessibility configuration process anonymously ● Provide information on which accessibility features are available as part of the courses ● Ask users which accessibility features they need to successfully complete the course ● Gather feedback about their experience using the accessibility features provided ● Provide assistance for users in accessible formats (chats, videoconferences, etc.) Some initial targets established for dissemination activities, as well as some examples of specific channels, are shown below. Activity Targets (minimum) Examples and comments Project website Hits from 50% of European countries Total hits 100/month Visitor statistics via an analytics tool will be recorded on the website to identify the country, but also interaction (measured via page depth, unique visitors and time on site) and referral sources (direct access, via Facebook or other social media platform) Press releases 3 per year, ideally in a variety of languages Updates on the achievement of milestones and other key findings Social media 2 videos across the time frame 2 Twitter updates/month 2 Facebook group posts/month Blog posts on platforms such as ▇▇▇.▇▇▇▇▇▇▇▇▇.▇▇ (social innovation community Europe); innov8social; European young innovators forum (EyIF); Number of views, followers and “likes” on our profile and updates will be recorded Con...

Pilot Phase. (1) Not later than * weeks in advance of commencing the Pilot Phase for a Product, Celltech shall supply and transfer to Biochemie all remaining Process Transfer Information that is reasonably required for Biochemie to Manufacture and deliver Product. (2) Upon completion of the Analytical Phase (unless otherwise determined by Celltech as stated in Clause 5(5) and subject to prior agreement by the parties of the Pilot Phase Protocol, Biochemie shall implement the Process in its facilities and Manufacture the Pilot Batches of Product, although not necessarily in compliance with Product Specifications, for the purpose of qualifying the Process. Biochemie will conduct all such activities only at its facilities located in Austria. The Pilot Phase shall run for an estimated period of * weeks, with the actual number of total weeks to be agreed upon by Celltech and Biochemie based on the results of the Pilot Phase. The parties acknowledge that Biochemie’s ability to conduct the Pilot Phase in accordance with this timetable is dependant on timely delivery (not later than * weeks in advance of commencing the Pilot Phase) by Celltech of agreed-upon Process Transfer Information and timely completion by Biochemie of the Analytical Phase. The parties agree to use their best endeavours to ensure that the timelines for the Analytical and Pilot Phases are met. (3) If during the Pilot Phase the parties identify an unforeseeable technical problem which prevents Biochemie from Manufacturing the Pilot Phase Batches, then the following procedure shall apply: (a) Biochemie may request further reasonable technical assistance from Celltech. (b) Biochemie shall use its best endeavors to resolve the problem to both parties’ satisfaction and Celltech shall be entitled to have a representative present at the Biochemie site and to fully participate in solving such problem to ensure that this provision is satisfied. (c) Save as provided in sub-Clause (3)(d) below, the additional cost of resolving the problem shall be borne by the party who is responsible for the problem, as mutually agreed by the parties, and if both parties are responsible then the cost shall be borne by both parties proportionally to the level of their respective fault. (d) If Pilot Phase was started before completion of the Analytical Phase at the direction of Celltech and the problem is a direct consequence of non-completion of the Analytical Phase, then the additional cost of resolving the problem shall be borne * ...

Pilot Phase. There were two phases of piloting. The first phase was carried out to assess whether the trauma films in the acquisition phase produced the conditioned fear response according to SCR amplitude and subjective ratings. Changes were then made to the protocol and the second piloting phase was completed to further assess whether the stimuli were producing the conditioned fear response and to assess the feasibility of the design. The pilot participants were recruited via email and were all staff or students at King’s College London. They all met inclusion criteria for the study and gave written informed consent. Four participants completed the first phase of piloting. 50% of these participants did not meet minimum response criteria for the conditioned SCR. The mean age of these participants was 27 (SD=1.73) and three of these participants were female and one was male. The intensive presentation phase was added to the protocol to attempt to produce a more consistent conditioned response. Nine participants (three per group) completed the second phase of piloting. The mean age of these participants was 27.5 (SD=2.69), eight participants were female and one was male. Eight participants (88%) showed a conditioned SCR above minimum criteria. All participants reported an increase in subjective ratings of distress to the CS+ after viewing the trauma films. The main aim of the piloting stage was to assess whether the stimuli produced the conditioned fear response at acquisition according to SCR and subjective distress ratings. SCR was inspected visually and 10 out of the 13 pilot participants had produced an SCR amplitude of greater than 0.02µs in response to the unreinforced CS+. Eight out of nine participants in the second phase acquired the conditioned fear response according to this criterion, which was after the addition of the intensive presentation phase. For the participants who also viewed the CS- following conditioning (n=6), there was a significant difference between subjective distress ratings to the CS+ (mean=56.67, SD=23.38) and the CS- (mean=0, SD=0) following

Pilot Phase. The fee for the Pilot Phase is $xxx,xxx (the “Pilot Phase Fee”), and is an irrevocable, nonrefundable commitment on the Effective Date. The Pilot Phase Fee will be invoiced on the Effective Date.